Intramuscular Hematomas Caused by Anticoagulant Therapy: Is Advanced Age a Risk Factor?

dc.authorid0000-0003-2016-9965en_US
dc.authorid0000-0003-2016-9965en_US
dc.authorid0000-0002-8936-0293en_US
dc.authorid0000-0002-2887-9235en_US
dc.contributor.authorCinar, Nilgun
dc.contributor.authorSahin, Sevki
dc.contributor.authorKaraoglan, Alper
dc.contributor.authorKarsidag, Sibel
dc.date.accessioned2024-07-12T21:52:32Z
dc.date.available2024-07-12T21:52:32Z
dc.date.issued2010en_US
dc.departmentMaltepe Üniversitesien_US
dc.description.abstractOral anticoagulant therapy (OAT) is very effective in the prevention of cerebral embolism, especially in certain cardiac diseases. Hematomas are the major complication of OAT. It may threaten the patient's life by bleeding into the vital structures. Herein, we describe four patients with hematomas in the psoas, quadriceps, pectoral, or rectus abdominis muscles accompanied by anemia during warfarin therapy for atrial fibrillation and artificial heart valves. Computed tomography and magnetic resonance imaging helped us establish a definitive diagnosis in each case. Our patients were three women and one man. Their international normalized ratios were within the therapeutic range during this period. They suffered from minor traumas, such as falls or a hit while taking warfarin therapy. All anticoagulation treatments were discontinued for approximately 1 week after the episode of bleeding. Although conservative management was sufficient for three patients, one patient had surgical decompression due to a rectus abdominis hematoma with retroperitoneal hemorrhage. There were no episodes of bleeding or other complications after starting oral anticoagulant therapy during the follow-up. The common aspects of our cases were older age and a history of minor trauma. As a result, we suggest that special attention needs to be paid to the patients under anticoagulant therapy, especially those at an advanced age, and to warn them avoid trauma. (Archives of Neuropsychiatry 2010;47:267-70)en_US
dc.identifier.doi10.4274/npa.5543
dc.identifier.endpage270en_US
dc.identifier.issn1300-0667
dc.identifier.issue3en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage267en_US
dc.identifier.trdizinid109588en_US
dc.identifier.urihttps://dx.doi.org/10.4274/npa.5543
dc.identifier.urihttps://hdl.handle.net/20.500.12415/8398
dc.identifier.volume47en_US
dc.identifier.wosWOS:000282653800015en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoenen_US
dc.publisherGALENOS YAYINCILIKen_US
dc.relation.ispartofNOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY03138
dc.subjectAnticoagulanten_US
dc.subjectcomplicationen_US
dc.subjecttraumaen_US
dc.subjectintramuscular hematomaen_US
dc.subjectpsoasen_US
dc.subjectquadricepsen_US
dc.subjectpectoralen_US
dc.subjectrectus abdominisen_US
dc.titleIntramuscular Hematomas Caused by Anticoagulant Therapy: Is Advanced Age a Risk Factor?en_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar